| Breakdown | TTM | Mar 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 52.05B | 53.72B | 51.12B | 48.22B | 44.69B | 42.15B |
| Gross Profit | 18.35B | 18.60B | 17.66B | 15.88B | 15.44B | 14.64B |
| EBITDA | 5.56B | 5.34B | 5.25B | 4.58B | 3.69B | 3.57B |
| Net Income | 2.21B | 2.39B | 2.20B | 1.93B | 1.61B | 1.47B |
Balance Sheet | ||||||
| Total Assets | 38.65B | 43.33B | 36.68B | 38.09B | 34.11B | 29.42B |
| Cash, Cash Equivalents and Short-Term Investments | 1.55B | 1.31B | 1.52B | 1.33B | 1.69B | 1.07B |
| Total Debt | 6.70B | 4.33B | 1.95B | 4.89B | 3.99B | 2.07B |
| Total Liabilities | 16.73B | 18.29B | 14.55B | 17.08B | 15.42B | 12.03B |
| Stockholders Equity | 21.92B | 25.03B | 22.12B | 20.99B | 18.65B | 17.35B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.51B | 4.24B | -944.80M | -404.22M | 1.91B |
| Operating Cash Flow | 0.00 | 3.84B | 6.07B | 2.67B | 2.45B | 2.91B |
| Investing Cash Flow | 0.00 | -5.21B | -1.83B | -3.55B | -2.37B | -958.78M |
| Financing Cash Flow | 0.00 | 1.14B | -4.08B | 457.30M | 398.44M | -2.05B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥68.23B | 7.81 | ― | 1.55% | 6.02% | 5.87% | |
69 Neutral | ¥48.79B | 12.53 | ― | 4.63% | 8.98% | 2.01% | |
65 Neutral | ¥29.35B | 12.93 | ― | 1.23% | 5.09% | 10.97% | |
65 Neutral | ¥210.40B | 12.79 | 13.33% | 3.47% | 3.37% | 5.12% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
61 Neutral | ¥35.67B | 16.19 | ― | 0.84% | 15.61% | -29.18% | |
49 Neutral | ¥59.88B | 513.85 | ― | 1.14% | 9.13% | -21.27% |